Defining the role of mass spectrometry in cancer diagnostics

被引：0
|
作者：
Semmes, OJ [1 ]
机构：
[1] Eastern Virginia Med Sch, Dept Microbiol & Cell Biol, Virginia Prostate Ctr, Norfolk, VA 23501 USA
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2004年 / 13卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1555 / 1557
页数：3
相关论文
共 50 条
  • [41] A vision for better health: Mass spectrometry imaging for clinical diagnostics
    Ye, Hui
    Gemperline, Erin
    Li, Lingjun
    CLINICA CHIMICA ACTA, 2013, 420 : 11 - 22
  • [42] Warning diagnostics for inductively coupled plasma-mass spectrometry
    Ying, H
    Murphy, J
    Tromp, JW
    Mermet, JM
    Salin, ED
    SPECTROCHIMICA ACTA PART B-ATOMIC SPECTROSCOPY, 2000, 55 (04) : 311 - 326
  • [43] Liquid chromatography-tandem mass spectrometry for clinical diagnostics
    不详
    NATURE REVIEWS METHODS PRIMERS, 2022, 2 (01):
  • [44] Mass spectrometry diagnostics of short-pulsed HiPIMS discharges
    Palmucci, Maria
    Britun, Nikolay
    Silva, Tiago
    Snyders, Rony
    Konstantinidis, Stephanos
    JOURNAL OF PHYSICS D-APPLIED PHYSICS, 2013, 46 (21)
  • [45] Mass Spectrometry in Cancer Diagnosis
    Nedved, Jan
    Hajduch, Marian
    Lemr, Karel
    Havlicek, Vladimir
    CHEMICKE LISTY, 2011, 105 (05): : 356 - 360
  • [46] The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science
    Ansari, Daniel
    Aronsson, Linus
    Sasor, Agata
    Welinder, Charlotte
    Rezeli, Melinda
    Marko-Varga, Gyorgy
    Andersson, Roland
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [47] The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science
    Daniel Ansari
    Linus Aronsson
    Agata Sasor
    Charlotte Welinder
    Melinda Rezeli
    György Marko-Varga
    Roland Andersson
    Journal of Translational Medicine, 12
  • [48] Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction
    Abelin, Jennifer G.
    Harjanto, Dewi
    Malloy, Matthew
    Suri, Prerna
    Colson, Tyler
    Goulding, Scott P.
    Creech, Amanda L.
    Serrano, Lia R.
    Nasir, Gibran
    Nasrullah, Yusuf
    McGann, Christopher D.
    Velez, Diana
    Ting, Ying S.
    Poran, Asaf
    Rothenberg, Daniel A.
    Chhangawala, Sagar
    Rubinsteyn, Alex
    Hammerbacher, Jeff
    Gaynor, Richard B.
    Fritsch, Edward F.
    Greshock, Joel
    Oslund, Rob C.
    Barthelme, Dominik
    Addona, Terri A.
    Arleta, Christina M.
    Rooney, Michael S.
    IMMUNITY, 2019, 51 (04) : 766 - +
  • [49] Defining the human kidney N-glycome in normal and cancer tissues using MALDI imaging mass spectrometry
    Drake, Richard R.
    McDowell, Colin
    West, Connor
    David, Fred
    Powers, Thomas W.
    Nowling, Tamara
    Bruner, Evelyn
    Mehta, Anand S.
    Angel, Peggi M.
    Marlow, Laura A.
    Tun, Han W.
    Copland, John A.
    JOURNAL OF MASS SPECTROMETRY, 2020, 55 (04):
  • [50] Defining the role of the RSK isoforms in cancer
    Houles, Thibault
    Roux, Philippe P.
    SEMINARS IN CANCER BIOLOGY, 2018, 48 : 53 - 61
12345